Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dennis Church is active.

Publication


Featured researches published by Dennis Church.


Drug Discovery Today | 2003

Chemical substructures in drug discovery.

Cedric Merlot; Daniel Domine; Christophe Cleva; Dennis Church

The widespread use of HTS and combinatorial chemistry techniques has led to the generation of large amounts of pharmacological data, which, in turn, has catalyzed the development of computational methods designed to reduce the time and cost in identifying molecules suitable for pharmaceutical development. This review focuses on the use of substructure-based in silico techniques for lead discovery, an effective and increasingly popular approach for augmenting the chance of selecting drug-like compounds for preclinical and clinical development.


Journal of Biological Chemistry | 2005

Bax Channel Inhibitors Prevent Mitochondrion-mediated Apoptosis and Protect Neurons in a Model of Global Brain Ischemia

Claudio Hetz; Pierre-Alain Vitte; Agnes Bombrun; Tatiana K. Rostovtseva; Sylvie Montessuit; Agnes Hiver; Matthias Schwarz; Dennis Church; Stanley J. Korsmeyer; Jean-Claude Martinou; Bruno Antonsson


Archive | 2003

Azolidinone-vinyl fused-benzene derivatives

Thomas Rueckle; Xuliang Jiang; Pascale Gaillard; Dennis Church; Tania Vallotton


Journal of Medicinal Chemistry | 2005

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-jun N-terminal kinase

Pascale Gaillard; Isabelle Jeanclaude-Etter; Vittoria Ardissone; Steve Arkinstall; Yves Cambet; Montserrat Camps; Christian Chabert; Dennis Church; Rocco Cirillo; Denise Gretener; Serge Halazy; Anthony Nichols; Cedric Szyndralewiez; Pierre-Alain Vitte; Jean-Pierre Gotteland


Archive | 2006

Pyrazine derivatives and use as pi3k inhibitors

Pascale Gaillard; Anna Quattropani; Vincent Pomel; Thomas Rueckle; Jasna Klicic; Dennis Church


Journal of Medicinal Chemistry | 2004

Design, synthesis, and biological activity of novel, potent, and selective (Benzoylaminomethyl)thiophene sulfonamide inhibitors of c-jun-N-terminal kinase

Thomas Rückle; Marco Biamonte; Tania Grippi-Vallotton; Steve Arkinstall; Yves Cambet; Montserrat Camps; Christian Chabert; Dennis Church; Serge Halazy; Xuliang Jiang; Isabelle Martinou; Anthony Nichols; Wolfgang Sauer; Jean-Pierre Gotteland


Archive | 2000

Benzazole derivatives and their use as jnk modulators

Serge Halazy; Dennis Church; Montserrat Camps; Pascale Gaillard; Jean-Pierre Gotteland


Archive | 2000

Pharmaceutically active sulfonamide derivatives

Stephen Arkinstall; Serge Halazy; Dennis Church; Montserrat Camps; Thomas Rueckle; Jean Pierre Gotteland; Marco Biamonte


Archive | 2001

Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases

Serge Halazy; Dennis Church; Stephen Arkinstall; Marco Biamonte; Montserrat Camps; Jean-Pierre Gotteland; Thomas Rueckle


Archive | 2001

Amine derivatives for the treatment of apoptosis

Serge Halazy; Matthias Schwarz; Bruno Antonsson; Agnes Bombrun; Jean-Claude Martinou; Dennis Church

Collaboration


Dive into the Dennis Church's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Serge Halazy

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

Jean-Pierre Gotteland

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Montserrat Camps

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge